Approved Programmed Cell Death-1 Inhibitors in Hodgkin Lymphoma: The first Breakthrough of Immune Checkpoint Inhibitors in Hematologic Malignancies

Approved Programmed Cell Death-1 Inhibitors in Hodgkin Lymphoma: The first Breakthrough of Immune Checkpoint Inhibitors in Hematologic Malignancies

Clinical Research in Hematology
Volume 1
Issue 1

Table of Contents

33
Views
2
Downloads
PDF
XML

Subscribe Newsletter

By subscribing you will get the latest news from us.

Quick Links

Others

Get in touch

Asclepius Open LLC

23191, Wrathall Dr, Ashburn, VA 20148,

USA

Email: support@asclepiusopen.com

© 2024 Asclepius Open LLC